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Purpose: Percutaneous transluminal angioplasty (PTA) is one of the treatment options for localized obstruction of the
subclavian artery. To document long-term durability of this kind of PTA we report a 10-year single-center experience in
110 patients.
Methods: From January 1993 to July 2003, 110 patients (72 women; mean age, 62  10 years) underwent PTA of
symptomatic (>75%) stenosis (n  90) or occlusion of the proximal subclavian artery (84 left-sided). Forty one patients
(37%) had symptoms of vertebrobasilar insufficiency, 29 patients (26%) had disabling chronic arm ischemia, and 20
patients had both symptoms. Twenty patients with coronary artery disease underwent PTA in preparation for myocardial
revascularization with the internal mammary artery. Duplex scans and arteriograms confirmed significant stenosis or
occlusion. All PTA procedures were performed with the patient under local anesthesia, through the femoral artery (n 
89), brachial artery (n  6), or combined route (n  15). In 59 patients (58%) an additional stent was placed.
Results: Angioplasty was initially technically and clinically successful in 102 patients (93%). Seven occlusions could not be
recanalized, and 1 procedure had to be stopped because of ischemic stroke. Of the 102 patients in whom treatment was
successful, 1 patient (1%) had a minor stroke in the contralateral hemisphere 2 hours post-PTA. Seven patients (7%) had
minor problems, all without permanent sequelae. Follow-up with duplex scanning ranged from 3 months to 10 years
(mean, 34 months). Primary clinical patency at 5 years was 89%, with a median recurrent obstruction–free period of 23
months. The local complication rate was 4.5%, and the combined stroke and death rate was 3.6%. Significant recurrent
obstruction (>70%) developed in 8 patients with clinical symptoms. Four stenoses were successfully treated with repeat
PTA (2 with additional stent placement); 4occlusions required surgery.
Conclusions: PTA of obstructive lesions of the proximal subclavian artery is not only an effective initial treatment, but is
also successful over the long-term. Inasmuch as all clinical failures occured within 26 months after initial therapy, we
recommend regular follow-up for at least 2 years post-PTA. All clinically significant recurrent stenoses can be treated with
repeat endovascular procedures. We could not prove positive or negative influence of additional placement of stents;
however, the number of recurrent stenoses might be too small in this retrospective study to draw firm conclusions.
Adverse events of any kind are certainly no greater than with invasive surgical procedures. Therefore PTA must be
seriously considered in patients with localized obstruction of the proximal subclavian artery. ( J Vasc Surg 2005;41:
19-23.)Obstruction of the subclavian artery is an important
cause of symptomatic extracranial cerebrovascular disease.1
Symptoms can be as severe as embolization to the fingers,2
subclavian steal syndrome,3 or even ischemic events in the
vertebrobasilar territory and coronary-subclavian steal,
which can lead to myocardial ischemia.4 More benign
symptoms are arm claudication, or weakness and paresthe-
sia related to arm exercise. Traditionally, surgical revascu-
larization was the preferred treatment option, with accept-
able long-term results.5 However, over the last 2 decades
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disease became an established therapy.6,7 Other investiga-
tors described good initial and mid-term results, mainly in
small groups of patients or a mixture of obstructive lesions
of all aortic arch vessels.8-9 Few authors focused on the
long-term durability of endovascular therapy for solitary
proximal subclavian artery obstructions, which was the
purpose of our study. We report a 10-year single-center
experience in 110 patients.
PATIENTS AND METHODS
Patients. Between January 1993 and July 2003, 200
patients were evaluated for symptoms of obstructive lesions
of the subclavian artery. Eighty patients had only mild arm
claudication, without other complaints, and did not need
surgical or endovascular intervention. In 8 patients with
long occlusions (5 cm) combined with severe calcifica-
tion, and 2 patients with occlusions very close to the
vertebral artery ostium, surgical revascularization was con-
sidered the optimal primary treatment. The remaining 110
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62  10 years) were referred for percutaneous treatment,
and are the subject of this study.
Forty one patients (37%) had clinical symptoms due to
vertebrobasilar insufficiency, 29 patients (26%) had dis-
Fig 1. Stenosis of proximal subclavian artery before (A) and after
(B) angioplasty with additional stent placement via transfemoral
route.abling arm ischemia (3 with peripheral emboli), and 20patients (18%) had both symptoms. In all 61 patients with
symptomatic vertebrobasilar insufficiency radiographic ret-
rograde flow was seen in the ipsilateral vertebral artery.
Twenty patients with coronary artery disease underwent
percutaneous transaminal angioplasty (PTA) in preparation
for myocardial revascularization with the internal mam-
mary artery.
All lesions were located in that part of the subclavian
artery proximal to the origin of the vertebral artery. The left
subclavian artery was most frequently involved (n  84,
76%), and all lesions were atherosclerotic.
Preprocedural examination included duplex scanning
of all extracranial arteries. Peak velocity ratio greater than
5.5 was defined as indicative of greater than 75% stenosis10
of the subclavian artery. In addition, if the ipsilateral verte-
bral artery originated from the subclavian artery and if there
was reverse flow in the vertebral artery, these were consid-
ered indicative of transient or permanent subclavian steal
syndrome. These criteria have been extensively validated in
our vascular laboratory, with angiography as the standard.
In all 110 patients digital subtraction angiography was
performed in at least 2 planes. Arteriograms confirmed
significant stenosis (75%) in 90 lesions and occlusion in
20 lesions (18%).
Methods. The procedures were performed in the an-
giosuite of the interventional radiology department, with
the patient under local anesthesia. All angioplasty proce-
dures were performed by 1 of 3 staff interventional radiol-
ogists, with the Seldinger technique. A femoral approach
was used in 89 patients, and a brachial approach in 6
patients. In 15 procedures, a combined femoral and bra-
chial approach was used.
For all transfemoral approaches, a short introduction
sheath and a guiding catheter or a long sheath were used.
After angiography of the aortic arch, selective catheteriza-
tion of the subclavian artery was performed, and the lesion
was crossed with a guide wire. When recanalization from
the femoral approach was not possible, brachial artery
access was established, and an attempt to recanalize from
that side was performed. Subsequent PTA or stent place-
ment was then performed through the femoral route. After
PTA a control angiogramwas obtained and the trans-lesion
pressure gradient was recorded. An additional stent was
placed only when the systolic intraaterial pressure gradient
across the lesion exceeded 5 mm Hg or greater than 20%
residual stenosis persisted. The only other reason for stent
placement was the occurrence of dissection. In all cases of
stenting, balloon-expandable stents were placed, because of
high accuracy of placement, with respect to the aortic arch
and vertebral artery, and high radial force.
Once the indication for PTAwas confirmed, all patients
received pre-treatment with 100 mg of aspirin daily. Intra-
venous heparin was administered during the procedure to
maintain an adequate activated clotting time. Aspirin was
then continued for at least 3 months post-procedure, and
dipyridamole was also given if stent placement was neces-
sary.
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12 months post-procedure, and annually thereafter. In
addition to medical history and clinical examination, du-
plex ultrasound scanning was performed in all patients. If
symptoms reoccurred and a greater than 50% recurrent
stenosis, according to duplex ultrasound criteria, was diag-
nosed, angiography was performed.
Initial technical success was defined as angiographic
residual stenosis less than 20%, with a gradient of less than
5 mm Hg across the treated lesion. Clinical failure was
defined as renewed clinical symptoms originating from
recurrent obstruction of the subclavian artery. The other
end point was death (PTA-related or non-PTA-related).
Cumulative clinical patency in all successfully treated pa-
tients was calculated with the life table method.
RESULTS
One hundred two of 110 patients (93%) underwent
technically successful PTA repair. A typical example of
successful revascularization is shown in Fig 1. Of the 8
failures, 7 failures (6 left-sided, 1 right-sided) were due to
occlusion of the proximal subclavian artery that was impos-
sible to traverse with a guide wire. Both femoral and
brachial approaches were attempted during these proce-
dures, but the calcification was too severe to enable passage.
These patients underwent subclavian-carotid bypass sur-
gery. In 1 patient, the procedure had to be stopped at
catheterization of the right subclavian artery before PTA
because of a major ischemic stroke in the ipsilateral hemi-
sphere. This patient, an 84-year-old woman, had 4-vessel
extracranial disease, with an incomplete circle ofWillis. One
week after the stroke she died of pulmonary insufficiency.
One of the 102 technically successful procedures was
complicated by occurrence of a minor stroke in the con-
tralateral left hemisphere. This ischemic event appeared 2
hours after the procedure. Seven other patients, all with
Fig 2. Life table analysis of primary clinical patency i
transluminal angioplasty of subclavian artery.left-sided lesions, had minor complications, includinggroin hematoma (n  3), peripheral emboli (n  2), and
amaurosis fugax (n  2), all without permanent sequelae.
The 2 patients with peripheral emboli were not the same
patients with pre-procedural finger emboli. Most of the 90
patients with pre-procedural symptoms (n  67, 74%)
reported complete relief, and the other patients (n  23,
26%) noted marked improvement, with mild arm dysbasia.
In all 61 patients with pre-procedural vertebrobasilar insuf-
ficiency antegrade flow was confirmed at duplex scanning
of the vertebral artery after the procedure.
Fifty-nine patients (58%) underwent additional stent
placement after PTA, primarily because of residual stenosis
greater than 20% (n  56). Three PTA-related dissections
could be successfully overstented. Fifty-one of 89 treated
stenotic lesions were treated with an additional stent (57%),
versus 8 in the 13 occluded arteries (61%, not significant).
No patients were lost to follow-up. Mean follow-up
with duplex scanning was 34 months (range, 3 months–10
years). Life table analysis of primary clinical patency is
shown in Fig 2. Significant recurrent obstruction developed
in 8 patients (recurrent stenosis75% in 4; occlusion in 4),
with renewed clinical symptoms. None of these patients
were in the group who neededmyocardial revascularization
or had pre-procedural peripheral emboli. Primary, none of
these patients had a subclavian artery occlusion. The four
recurrent stenoses were successfully treated with repeat PTA,
with additional stent placement in 2 patients. In 4 patients
occlusions could not be recanalized, and surgical intervention
was necessary. In 5 of 8 patients recurrent obstruction was
initially treatedwith additional stent placement.No significant
difference was found between stented or not stented stenotic
lesions insofar as recurrent obstruction rate. The median re-
current obstruction–free period was 23 months. Six patients
had 50% to 70% stenosis on duplex scans and arteriograms,
but were without symptoms, so no repeat intervention was
ients with initially technically successful percutaneousn patnecessary.
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deaths were related to extracranial vessel disease or the
initial PTA procedure.
DISCUSSION
Symptomatic occlusive disease of the upper extremities
is much less common than in the lower extremities, ac-
counting for limb ischemia in approximately 5% of pa-
tients.10 In our study population, 61 patients had signs of
vertebrobasilar insufficiency. All had reversal of blood flow
in the ipsilateral vertebral artery at duplex scanning, which
proves subclavian steal syndrome. Three patients had pe-
ripheral emboli to the hand, and 20 patients received
treatment before a planned bypass operation using the left
internal mammary artery. In the literature, these criteria (in
76% of our study population) are sure indications to inter-
vene in subclavian artery obstruction.12 As in other stud-
ies,13,14 the obstructive lesions in our patients were located
in the proximal segment of the subclavian artery, proximal
to the origin of the vertebral artery and predominantly on
the left side.15 It is likely that turbulent flow patterns in the
aortic arch and at the origin of the subclavian artery are
responsible for extensive plaque formation at this particular
location.
Our initial technical success rate of 93% in the entire
patient group is at least comparable with that of other
series.16,17 The initial technical success rate for stenosis was
100% (89 of 89), and for occlusions 65% (13 of 20).
Despite improvement in endovascular equipment and tech-
niques over the last decade, occlusions, even small occlu-
sions, are still a barrier to success in this area of endovascular
revascularization. On an intention-to-treat basis, the local
complication rate is 4.5%, and the combined stroke and
death rate is 3.6%. All four (4%) cerebrovascular complica-
tions were of hemispheric origin. Aside from the major
stroke, each of the ischemic events (minor stroke in 1
patient, amaurosis fugax in 2 patients) occurred either at
the end of the procedure or after the procedure. Apparently
this is due to thromboemboli resulting from catheter and
guide wire manipulation, despite adequate amounts of
heparin. The 2 patients with major or minor stroke had
multiple-vessel extracranial disease in combination with a
right-sided subclavian artery obstruction. PTA of the right
subclavian artery is generally believed to be a riskier proce-
dure, even without extensive extracranial artery disease,
because of the proximity of the common carotid artery. It
can be assumed that patients with this combination of
disease are at higher risk for thromboembolic complica-
tions of the carotid and middle cerebral arteries. Subclavian
artery transposition in these patients might be a useful
alternative.
No specific vertebrobasilar ischemic events occured
during revascularization. It is generally accepted that dur-
ing PTA of the subclavian artery in patients with subclavian
steal phenomenon, reverse flow in the ipsilateral vertebral
artery protects the brain against microemboli.18 This re-
verse flow persists for some time after PTA.During follow-up, all patients were examined by the
same vascular surgeons, and only if there was any doubt a
patient was re-examined by a neurologist. This might be a
limitation of this study. Because of the retrospective nature
of the study, we could not determine whether preventive
therapy (eg, statin drugs) or lifestyle affected the degree of
recurent stenosis, which is another limitation.
The long-term clinical results of PTA are satisfactory,
with a 5-year primary patency rate of 89%. All symptomatic
recurrent obstructions occurred within 26 months after
initial therapy. Apparently, intima hyperplasia from PTA-
related injury is the main cause for these early failures.
There was no significant difference between stented and
nonstented arteries insofar as recurrent stenosis rate. Of the
8 patients with clinically significant recurrent obstructions,
the 4 recurrent stenoses could be efffectively treated with
repeat endovascular therapy. This was contrary to our ex-
perience with the occlusive lesions. Of interest, none of the
13 successfully recanalized occlusions restenosed. No sig-
nificant difference was found focussing on the percentage
of stented stenotic and occluded lesions (57% vs 61%, not
significant), but the number of patients in this retrospective
study is too small to draw firm conclusions.
Six patients had 50% to 70% recurrent stenosis accord-
ing to duplex ultrasound and angiography criteria, but
none had symptoms and repeat intervention was not nec-
essary. Duplex scans confirmed the absence of steal phe-
nomenon in the ipsilateral vertebral artery, which proves
sufficient flow in the subclavian artery or collateral vessels.
In conclusion, PTA of obstructive lesions of the prox-
imal subclavian artery is not only an effective initial treat-
ment, but also is successful over the long term, with a 5-year
primary clinical patency rate of 89%. Inasmuch as all clinical
failures occured within 26 months after initial therapy, and
all clinically significant recurrent stenoses could be treated
with repeat endovascular procedures, we recommend reg-
ular follow-up for at least 2 years post-PTA. Occluded
lesions had a less favorable initial technical success rate
compared with stenotic lesions. However, no patients with
an occluded artery had any adverse effects from the endo-
vascular attempt, and could be successfully operated on
thereafter. We could not prove positive or negative influ-
ence of additional placement of stents; however, the num-
ber of patients with recurrent stenosis might be too small in
this retrospective study to draw firm conclusions.
Adverse events of any kind, including a stroke and
death rate of 3.6% and a local complication rate of 4.5%, are
certainly no greater than with invasive surgical procedures.9
Therefore, PTA must be seriously considered in patients
with localized obstruction of the proximal subclavian ar-
tery.
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Dr T. Bower (Rochester, Minn). Dr de Vries and colleagues
have just reported one of the larger clinical series of percutaneous
transluminal angioplasty of the subclavian artery. I have several
comments and 3 questions.
You state that these lesions were solitary, and yet 1 patient
with a stroke had 4-vessel disease. As you know, in the absence of
microemboli, subclavian lesions are often asymptomatic unless
there are associated lesions of the great vessels, the carotid bifur-
cations, the vertebral arteries, or the intracranial circulation. Can
you define the extent of such disease in your patients.
This has implications because more than half of your patients
had vertebral basilar insufficiency, a symptom complex with many
possible causes. How confident are you that the subclavian lesions
contributed to those symptoms? You mention that no late deaths
were due to subclavian artery disease. Were any of them due to
carotid disease?
The real question, as I see it, is the role of subclavian angio-
plasty in general. Excellent results of transposition and carotid
subclavian bypass have been reported in the United States and
Europe. Stroke and death rates are less than 1%, and 5-year and
10-year patency rates are as high as 90% to 100%. Most patients
leave the hospital within 2 days. What selection criteria do you now
use, based on these data, for angioplasty or operation, or do you
think that everyone should be approached with angioplasty alone?
Dr Jean-Paul de Vries. The majority of patients in our study
group had solitary lesions of the subclavian artery, and all patients
with vertebral insufficiency had a proven radiographic reversed
flow in the vertebral artery, which was antegrade after the proce-
dure. In my opinion, a solitary subclavian artery stenosis or occlu-
sion may be responsible for most complaints in these patients.
In literature the initial and long-term results of surgical and
endovascular revascularization of the subclavian artery are compa-
rable. Therefore, we believe that the less invasive endovascular
technique might be the preferential treatment, as it is in ourDr R. Greenberg (Cleveland, Ohio). I have a question really
on the breakdown of patients between those with stenoses or
occlusions. If I read the abstract correctly, there were only 20
patients with occlusions. And based on your complications, really,
the technical success in that subset of patients was just over 50%.
Can you really make any conclusions related to the long-term
results, or even the short-term results, of treating subclavian artery
occlusions with an interventional technique, given the disparity of
the outcomes for stenoses and occlusions?
Dr de Vries. There is a marked difference in initial success
rates. In stenosis it was 100% in up to 90 lesions and 65% in the 20
occlusions. However, during long-term follow-up, no patients
who were primarily successfully treated for occlusions had resteno-
sis or reocclusion.
It seems that when the initial procedure is successful in pa-
tients with occlusions, they have a good long-term follow-up.
However, it is a small patient group of 13 patients, so we must not
draw very firm conclusions from it, I think.
Dr J. Wolfe (London, England). I don’t think that we can
consider this sort of intervention, whether it’s surgical or balloon
dilation, as totally benign. I mean, your stroke risk was nearly 2%.
My question is, what is the pool of patients in which you
perform these procedures? You were doing approximately 1 inter-
vention a month during that decade. And certainly, I think, as a lot
of our experience is, most of these patients are relatively asymp-
tomatic, and it is questionable whether anything at all needs to be
done. And I would say that probably somewhere between 10% and
20% of patients with subclavian stenosis need treatment, which
means that you were seeing really quite a large number of stenoses
if you’re interfering at this number, or you’re interfering in a
significant number of the patients who were referred to you. What
I’d like to know is, how many patients were referred with subcla-
vian stenosis to produce this number of interventions?
Dr de Vries. Two hundred patients were referred to our
clinic. So 90 patients were conservatively treated by us with suc-
cess.
